- Home
- ACXP vs CLNN Comparison
ACXP vs CLNN Comparison
Compare ACXP & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- CLNN
- Stock Information
- Founded
- ACXP 2017
- CLNN 2012
- Country
- ACXP United States
- CLNN United States
- Employees
- ACXP N/A
- CLNN N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- ACXP Health Care
- CLNN Health Care
- Exchange
- ACXP Nasdaq
- CLNN Nasdaq
- Market Cap
- ACXP 31.4M
- CLNN 37.7M
- IPO Year
- ACXP 2021
- CLNN N/A
- Fundamental
- Price
- ACXP $0.46
- CLNN $4.54
- Analyst Decision
- ACXP Strong Buy
- CLNN Strong Buy
- Analyst Count
- ACXP 1
- CLNN 4
- Target Price
- ACXP $12.00
- CLNN $55.25
- AVG Volume (30 Days)
- ACXP 472.4K
- CLNN 41.1K
- Earning Date
- ACXP 03-18-2025
- CLNN 05-07-2025
- Dividend Yield
- ACXP N/A
- CLNN N/A
- EPS Growth
- ACXP N/A
- CLNN N/A
- EPS
- ACXP N/A
- CLNN N/A
- Revenue
- ACXP N/A
- CLNN $421,000.00
- Revenue This Year
- ACXP N/A
- CLNN N/A
- Revenue Next Year
- ACXP N/A
- CLNN N/A
- P/E Ratio
- ACXP N/A
- CLNN N/A
- Revenue Growth
- ACXP N/A
- CLNN N/A
- 52 Week Low
- ACXP $0.43
- CLNN $3.82
- 52 Week High
- ACXP $3.33
- CLNN $9.80
- Technical
- Relative Strength Index (RSI)
- ACXP 30.04
- CLNN 50.45
- Support Level
- ACXP $0.60
- CLNN $4.31
- Resistance Level
- ACXP $0.67
- CLNN $4.66
- Average True Range (ATR)
- ACXP 0.07
- CLNN 0.33
- MACD
- ACXP -0.03
- CLNN 0.02
- Stochastic Oscillator
- ACXP 6.99
- CLNN 57.69
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).